ILUVIEN® Received FDA Approval with Commercial Launch Anticipated in the First Quarter of 2015; additional patent granted in U.S. covering formulation through August 2027
$2.4 Million Net Revenue Achieved Through Sales of ILUVIEN in Germany and the United Kingdom; Shipments Up Over 30% in the United Kingdom Alimera Will Host a Conference Call at 4:30 PM ET Today ATLANTA , Nov.
SAN FRANCISCO, CA --
Corporation (NYSE:ECOM), a leading provider of cloud-based e-commerce
solutions that enable retailers and manufacturers to increase global
sales, today announced the acquisition of E-Tale Holdings Limited, a
UK-based company that offers a leading global “Where to Buy” solution.
Kemper Corporation (NYSE: KMPR)
reported today net income of $4.7 million, or $0.09 per diluted share,
for the third quarter of 2014, compared to $70.1 million, or $1.23 per
diluted share, for the third quarter of 2013.
Display Corporation (Nasdaq: OLED), enabling energy-efficient
displays and lighting with its UniversalPHOLED ®
technology and materials, today reported financial results for the third
quarter ended September 30, 2014.
Technology Growth Capital, Inc. (NYSE: HTGC) (“Hercules” or the
“Company”), the leading specialty finance company focused on providing
senior secured loans to venture capital-backed companies in
technology-related markets, including technology, biotechnology, life
science, and energy & renewable technology industries, at all stages of
development, announced today its financial results for the third quarter
ended September 30, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.